why is CNC "Undervalued"

Centene Corporation (CNC) is considered "undervalued" for several reasons: 1. **Mixed Q2 Results**: Despite challenges, Centene reported a 17% increase in premium and service revenues to $42.5 billion, highlighting its strong market position. 2. **Strategic Focus**: Centene's guidance for the remainder of 2025 emphasizes a strategic focus on adapting to market changes and enhancing value delivery to stakeholders. This indicates a proactive approach to addressing challenges and improving performance. 3. **Market Position**: Centene's substantial market capitalization, strong revenue growth, and significant market presence in 29 states, with 22 states meeting expected growth, suggest a solid business foundation. 4. **Valuation Metrics**: With a P/E ratio below 15 and a revenue growth rate above 10%, Centene's valuation metrics indicate a reasonable price-to-earnings ratio and strong revenue growth, which are typically associated with undervaluation. These factors combined suggest that Centene may be trading below its intrinsic value, making it an attractive investment opportunity for those who believe in its long-term potential. Sector is Healthcare; Market Capitalization > $10 billion; P/E Ratio < 15; Revenue YoY Growth Rate > 10% |code|stock code|stock name|Last Price|Last Change|GICS Sector|Market Cap[20250725]|P/E(TTM)[20250725]|Total Revenue Yoy Growth[20250725]|Total Revenue[20250725]|Report End Date[20250725]|Fiscal Date[20250725]|Report Period[20250725]|market_code| |---|---|---|---|---|---|---|---|---|---|---|---|---|---| |ELV|ELV.N|Elevance Health|289.1|3.091681|Health Care|6.50990476864E10|12.145344|14.82960283721258|4.8891E10|20250331|20250331|2025Q1|169| |ALNY|ALNY.O|Alnylam Pharmaceuticals|328.81|0.24695099999999998|Health Care|4.287300750233E10|-158.964955|20.20014848290525|5.94189E8|20250331|20250331|2025Q1|185| |ONC|ONC.O|Beigene|291.47|-1.6831949999999998|Health Care|3.1463314018191E10|-80.188686|48.64312208309165|1.117279E9|20250331|20250331|2025Q1|185| |INSM|INSM.O|Insmed|103.95|0.415379|Health Care|1.974545042085E10|-19.486975|22.94437086092715|9.2823E7|20250331|20250331|2025Q1|185| |NTRA|NTRA.O|Natera|138.9|-1.534753|Health Care|1.8966319962E10|-99.947407|36.46289100209115|5.0183E8|20250331|20250331|2025Q1|185| |GMAB|GMAB.O|Genmab|23.4|-0.973339|Health Care|1.5012095436E10|13.788391|43.720853890873585|1.03310554761E9|20241231|20241231|2024Q4|185| |CNC|CNC.N|Centene|28.39|6.091181|Health Care|1.412694917E10|6.877774|15.3760487044324|4.662E10|20250331|20250331|2025Q1|169| |UTHR|UTHR.O|United Therapeutics|304.5|-0.623348|Health Care|1.37349667035E10|11.344649|17.220008853474987|7.944E8|20250331|20250331|2025Q1|185|